Ebbesen Finn, Madsen Poul H, Rodrigo-Domingo Maria, Donneborg Mette L
Department of Pediatrics, Aalborg University Hospital, Aalborg, Denmark.
Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark.
Pediatr Res. 2025 Apr;97(5):1623-1628. doi: 10.1038/s41390-024-03493-w. Epub 2024 Sep 4.
The clinical part of this randomized controlled trial concerning phototherapy of neonates with hyperbilirubinemia showed that the recommended blue-green LED light (≈478 nm) was 31% more efficient than standard blue LED light (≈459 nm) measured by the decline in total serum bilirubin. Lumirubin has biologic effects. The aim was to compare the serum bilirubin isomers, efficacy, and biologic effects between the two phototherapy groups.
Inclusion criteria: neonates healthy except for hyperbilirubinemia, gestational age ≥33 weeks, birth weight ≥1800 g, and postnatal age >24 h. Forty-two neonates were randomized to receive overhead blue-green light and 44 blue light. Treatment 24 h. The light irradiance was equal.
The percentage decrease of combined bilirubin isomers was 47.8% for blue-green light vs 33.4% for blue light, the ratio being 1.43. Corresponding values for Z,Z-bilirubin were 55.6% vs 44.2%, the ratio being 1.26. The increase in the absolute serum concentrations of the photoisomer Z,E-bilirubin and thereby combined photoisomers were greater using blue light.
Blue-green light was essentially more efficient determined by the decline of combined bilirubin isomers and Z,Z-bilirubin itself. Regarding biological effects neonates receiving blue-green light might be more affected than neonates receiving blue light.
Phototherapy of hyperbilirubinemic neonates using blue-green LED light with a peak emission of 478 nm was 43% more efficient than standard blue LED light with a peak emission of 459 nm was measured by the decline of serum combined bilirubin isomers, and the decline of toxic Z,Z-bilirubin was 26% greater. Apparently, there was a discrepancy between the huge drop in total serum bilirubin and the low serum concentrations of E,Z-bilirubin and E,Z-lumirubin. This was caused by the rapid excretion of E,Z-lumirubin. Lumirubin has biologic effects. Due to greater lumirubin production neonates exposed to blue-green light might be more affected than those exposed to blue light.
这项关于新生儿高胆红素血症光疗的随机对照试验的临床部分表明,通过总血清胆红素的下降来衡量,推荐的蓝绿色发光二极管灯(≈478纳米)比标准蓝色发光二极管灯(≈459纳米)效率高31%。光红素具有生物学效应。目的是比较两个光疗组之间的血清胆红素异构体、疗效和生物学效应。
纳入标准:除高胆红素血症外健康的新生儿,胎龄≥33周,出生体重≥1800克,出生后年龄>24小时。42例新生儿随机接受头顶蓝绿光照射,44例接受蓝光照射。治疗24小时。光照强度相同。
蓝绿色光照射下结合胆红素异构体的下降百分比为47.8%,蓝光照射下为33.4%,比值为1.43。Z,Z-胆红素的相应值分别为55.6%和44.2%,比值为1.26。使用蓝光时,光异构体Z,E-胆红素以及由此产生的结合光异构体的绝对血清浓度增加更大。
根据结合胆红素异构体和Z,Z-胆红素本身的下降情况,蓝绿色光本质上更有效。关于生物学效应,接受蓝绿色光的新生儿可能比接受蓝光的新生儿受到更大影响。
通过血清结合胆红素异构体的下降来衡量,使用峰值发射波长为478纳米的蓝绿色发光二极管灯对高胆红素血症新生儿进行光疗比峰值发射波长为459纳米的标准蓝色发光二极管灯效率高43%,毒性Z,Z-胆红素的下降幅度大26%。显然,总血清胆红素的大幅下降与E,Z-胆红素和E,Z-光红素的低血清浓度之间存在差异。这是由于E,Z-光红素的快速排泄所致。光红素具有生物学效应。由于光红素产生量更大,暴露于蓝绿色光的新生儿可能比暴露于蓝光的新生儿受到更大影响。